These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7739500)

  • 21. Genetics and natural history of multiple sclerosis.
    Kantarci OH
    Semin Neurol; 2008 Feb; 28(1):7-16. PubMed ID: 18256983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M; Rice GP; Baskerville J; Wingerchuk DM; Ebers GC
    Brain; 2006 Mar; 129(Pt 3):584-94. PubMed ID: 16401620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Survival in disseminated sclerosis in Denmark. A nation-wide study of the period 1948-1986].
    Brønnum-Hansen H; Koch-Henriksen NJ; Hyllested K
    Ugeskr Laeger; 1995 Dec; 157(51):7131-5. PubMed ID: 8545927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disability progression in multiple sclerosis is slower than previously reported.
    Tremlett H; Paty D; Devonshire V
    Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplantation for multiple sclerosis.
    Burt RK; Burns W; Hess A
    Bone Marrow Transplant; 1995 Jul; 16(1):1-6. PubMed ID: 7581107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis in Australia: prognostic factors.
    Hammond SR; McLeod JG; Macaskill P; English DR
    J Clin Neurosci; 2000 Jan; 7(1):16-9. PubMed ID: 10847644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The natural history of multiple sclerosis].
    Kremenchutzky M
    Rev Neurol; 2000 May 16-31; 30(10):967-72. PubMed ID: 10919197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.
    Weinshenker BG; Bass B; Rice GP; Noseworthy J; Carriere W; Baskerville J; Ebers GC
    Brain; 1989 Feb; 112 ( Pt 1)():133-46. PubMed ID: 2917275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What role does tobacco smoking play in multiple sclerosis disability and mortality? A review of the evidence.
    Weston M; Constantinescu CS
    Neurodegener Dis Manag; 2015; 5(1):19-25. PubMed ID: 25711451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of multiple sclerosis.
    Weinshenker BG; Ebers GC
    Can J Neurol Sci; 1987 Aug; 14(3):255-61. PubMed ID: 3311324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.
    Weinshenker BG; Bass B; Rice GP; Noseworthy J; Carriere W; Baskerville J; Ebers GC
    Brain; 1989 Dec; 112 ( Pt 6)():1419-28. PubMed ID: 2597989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality in patients with multiple sclerosis.
    Scalfari A; Knappertz V; Cutter G; Goodin DS; Ashton R; Ebers GC
    Neurology; 2013 Jul; 81(2):184-92. PubMed ID: 23836941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multiple sclerosis or demyelinating diseases].
    Kuroiwa Y
    Naika; 1966 Feb; 17(2):247-50. PubMed ID: 5960000
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pathophysiology of multiple sclerosis].
    Brassat D
    Presse Med; 2010 Mar; 39(3):341-8. PubMed ID: 20171040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvements to a simple Markov model of the natural history of multiple sclerosis. I. Short-term prognosis.
    Wolfson C; Confavreux C
    Neuroepidemiology; 1987; 6(3):101-15. PubMed ID: 3658079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of multiple sclerosis.
    Weinshenker BG
    Ann Neurol; 1994; 36 Suppl():S6-11. PubMed ID: 8017890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study.
    Harirchian MH; Babaie S; Keshtkaran N; Bitarafan S
    Curr J Neurol; 2023 Jan; 22(1):30-34. PubMed ID: 38011361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.